Abstract
Along the time, the definition of acute rejection has been modified according to the successive Banff classifications, the use of C4d and the identification of anti- HLA antibodies. Both cellular and humoral acute rejection are nowadays considered to be different with regard to definition, pathogenesis and hence treatment. The Banffclassification remains a very useful tool to improve the precision of these definitions. The new technologies such as microarrays should help to identify new aspects of acute rejection.
MeSH terms
-
Acute Disease
-
Biomarkers / blood*
-
Complement Activation / immunology
-
Complement C4b
-
Graft Rejection / immunology*
-
Graft Rejection / pathology
-
Graft Survival / immunology
-
HLA Antigens / blood
-
Humans
-
Immunologic Factors / blood
-
Isoantibodies / blood
-
Kidney Failure, Chronic / surgery
-
Kidney Transplantation / immunology*
-
Kidney Transplantation / pathology
-
Kidney Transplantation / trends
-
Peptide Fragments / blood
-
Prognosis
-
Transplantation, Homologous / immunology
Substances
-
Biomarkers
-
HLA Antigens
-
Immunologic Factors
-
Isoantibodies
-
Peptide Fragments
-
Complement C4b
-
complement C4d